Media Center

Human Model Background ImagePress Releases
December 6, 2019

3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

NEW YORK, December 6, 2019 /PRNewswire/ — 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted…
Abstract Background ImagePress Releases
November 19, 2019

3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced it has received Orphan Drug Designation for AuriNovo™, an investigational…
Abstract Background ImagePress Releases
April 2, 2019

3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors

NEW YORK, April 2, 2019 /PRNewswire/ --  3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced the appointment of Sol Barer, Ph.D. and…
Pod cast IconNews
October 23, 2021

3DBio on Finding Genius Podcast

Finding Genius Podcast (Oct. 23, 2021 Episode) 3DBio: Printing Living Human Tissues for Therapeutic Applications   Press play to learn: The most common problems with synthetic implants How 3D bioprinting…
Living ear tissue bioprinted by 3DBio Therapeutics.News
November 5, 2020

Axios: Bioprinted Living Tissue Aims for Clinical Trial

Bryan Walsh, author of Future Axios Living ear tissue bioprinted by 3DBio Therapeutics. Photo: 3DBio Therapeutics A startup is applying for clinical trials of its method of 3D bioprinting living ear…